New River Continues To Climb
Shares of New River Pharmaceuticals Inc. (NRPH) continued to rise over the FDA's decision on the company's attention deficit hyperactivity disorder treatment. The stock price jumped another $5.50 to close at $47.82.
0 Comments:
Post a Comment
<< Home